The German Monopoly Commission published its special report “Telecommunications 2015: Markets in flux”, evaluating the situation and development of competition on the telecommunications market. The Monopoly Commission said it appreciated the work of the Federal Network Agency (BNetzA) as mainly positive. It said some fixed-line regulations could be abandoned, but regulation of access to Deutsche Telekom’s infrastructure was still essential to sustain alternative providers of advanced broadband services.
The competition regulator approved the use of a regional market approach for bitstream access, helping to end regulation in certain areas. However it is concerned about the BNetzA’s recent decision to allow DT to go ahead with the roll-out of vectoring technology. The Commission supports the use of the technology, but said the networks regulator had set high barriers for alternative operators to participate in the new technology. The Commission warned that the BNetzA’s approach may not be able to prevent the re-establishment of a monopoly by DT on the last mile.
The commission also reiterated its stance that the federal government should sell its 32-percent stake in Deutsche Telekom soon, in order to resolve the conflict of interest resulting from the dual role of legislator and shareholder. The sale would also generate substantial funds, which could potentially be used to subsidise the broadband expansion in Germany.
Full content: Telecom Paper
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas